These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 837336)

  • 41. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre- and post-magnetic resonance imaging features of suspicious internal mammary lymph nodes in breast cancer patients receiving neo-adjuvant therapy: Are any imaging features predictive of malignancy?
    Patel S; Delikat A; Liao J; Chetlen AL
    Breast J; 2018 Nov; 24(6):997-1000. PubMed ID: 30066351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study.
    Madsen EV; Aalders KC; van der Heiden-van der Loo M; Gobardhan PD; van Oort PM; van der Ent FW; Rutgers EJ; Valdés Olmes RA; Elias SG; van Dalen T
    Ann Surg Oncol; 2015 Dec; 22(13):4254-62. PubMed ID: 25808100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
    Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
    Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
    Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
    Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thoracoscopic approach in the treatment of breast cancer relapse in the internal mammary lymph node.
    Conrado-Abrão F; Das-Neves-Pereira JC; Fernandes A; Jatene FB
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):328-30. PubMed ID: 20576656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
    Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
    Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Internal mammary lymph node metastases in breast cancer: what should radiologists know?
    Urano M; Denewar FA; Murai T; Mizutani M; Kitase M; Ohashi K; Shiraki N; Shibamoto Y
    Jpn J Radiol; 2018 Nov; 36(11):629-640. PubMed ID: 30194586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
    Rosen PP; Lesser ML; Kinne DW; Beattie EJ
    Ann Surg; 1983 Mar; 197(3):276-83. PubMed ID: 6830335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis.
    Smith JA; Gamez-Araujo JJ; Gallager HS; White EC; McBride CM
    Cancer; 1977 Feb; 39(2):527-32. PubMed ID: 837335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of operable breast cancer: the surgeon's view.
    Urban JA
    Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.